Satellos Bioscience (TSX:MSCL) Price-to-Tangible-Book : 1.44 (As of May. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Price-to-Tangible-Book?

As of today (2024-05-12), Satellos Bioscience's share price is C$0.47. Satellos Bioscience's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was C$0.33. Hence, Satellos Bioscience's Price to Tangible Book Ratio of today is 1.44.

The historical rank and industry rank for Satellos Bioscience's Price-to-Tangible-Book or its related term are showing as below:

TSX:MSCL' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.32 Med: 5.61 Max: 9.9
Current: 1.42

During the past 4 years, Satellos Bioscience's highest Price to Tangible Book Ratio was 9.90. The lowest was 1.32. And the median was 5.61.

TSX:MSCL's Price-to-Tangible-Book is ranked better than
77.07% of 1221 companies
in the Biotechnology industry
Industry Median: 2.7 vs TSX:MSCL: 1.42

A closely related ratio is called PB Ratio. As of today, Satellos Bioscience's share price is C$0.47. Satellos Bioscience's Book Value per Sharefor the quarter that ended in Dec. 2023 was C$0.36. Hence, Satellos Bioscience's P/B Ratio of today is 1.30.

Satellos Bioscience Price-to-Tangible-Book Historical Data

The historical data trend for Satellos Bioscience's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Price-to-Tangible-Book Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

9.90

1.32

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial									-	-	1.17	1.17	1.32

Competitive Comparison of Satellos Bioscience's Price-to-Tangible-Book

For the Biotechnology subindustry, Satellos Bioscience's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Satellos Bioscience's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's Price-to-Tangible-Book falls into.

Satellos Bioscience Price-to-Tangible-Book Calculation

Satellos Bioscience's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.47	/	0.326
	=	1.44

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Satellos Bioscience Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience (TSX:MSCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0IT:Germany

Address

65 Front Street East, Suite 201, Toronto, ON, CAN, M5E 1B5

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience (TSX:MSCL) Headlines

No Headlines